Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours Journal Article


Authors: Ghossein, R. A.; Bhattacharya, S.
Article Title: Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours
Abstract: The detection and molecular characterisation of circulating tumour cells (CTC) and micrometastases may have important prognostic and therapeutic implications. Because their numbers are very small, these tumour cells are not easily detected using conventional methods. In the last decade, numerous groups have attempted to detect occult tumour cells in solid malignancies using the highly sensitive reverse transcriptase polymerase chain reaction (RT-PCR). These assays were in the vast majority directed against tissue-specific markers. PCR was shown to be superior to conventional techniques in detecting occult tumour cells allowing the identification of one malignant cell mixed with 1-10 million normal cells. In some tumours like melanoma and prostatic carcinoma, tissue-specific transcripts were detected with high specificity in the blood of patients with localised and advanced disease. In some reports, PCR was shown to be a strong predictor of poorer outcome. However, due to the many limitations of PCR (e.g false-positives), many groups are developing new approaches for the detection of occult tumour cells. The most attractive technique involves immunomagnetic isolation of CTC and micrometastases prior to downstream analysis. The tumour-rich magnetic fraction can be subjected to RT-PCR, immunocytochemistry and in situ hybridisation. This will lead to better quantification and molecular characterisation of these tumour cells. In conclusion, the molecular detection and characterisation of occult tumour cells offer a great opportunity for better stratifying patients with solid tumours and for developing new prognostic markers and targeted therapies. Copyright (C) 2000 Elsevier Science Ltd.
Keywords: immunohistochemistry; review; solid tumor; polymerase chain reaction; melanoma; metastasis; reverse transcription polymerase chain reaction; genetic transcription; breast neoplasms; gastrointestinal neoplasms; prostatic neoplasms; in situ hybridization; cancer genetics; immunocytochemistry; minimal residual disease; reverse transcriptase polymerase chain reaction; breast carcinoma; neoplasm metastasis; melanoma cell; lung carcinoma; prostate carcinoma; molecular diagnostics; neoplasm circulating cells; humans; human; male; female; priority journal; reverse transcriptase
Journal Title: European Journal of Cancer
Volume: 36
Issue: 13
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2000-08-01
Start Page: 1681
End Page: 1694
Language: English
DOI: 10.1016/s0959-8049(00)00152-0
PUBMED: 10959054
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 18 November 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ronald A Ghossein
    482 Ghossein